Efficacy and Safety of Varied Bisphosphonate Therapy Dosing in Patients With Hypercalcemia of Malignancy
Bisphosphonates were equally efficacious in normalizing serum calcium in patients with HCM. Pamidronate 90 mg was not more efficacious than 60 mg. Rates of refractory hypocalcemia were similar.
Authors
- Sydney Schultz (ORCID: https://orcid.org/0000-0001-9689-8123)
- Nelson Leung (ORCID: https://orcid.org/0000-0002-5651-1411)
- Jason N. Barreto (ORCID: https://orcid.org/0000-0003-2146-5766)
- Grace M. Choong (ORCID: https://orcid.org/0000-0002-9668-6072)
- Kristin Cole (ORCID: https://orcid.org/0000-0002-8783-0191)
- Yucai Wang (ORCID: https://orcid.org/0000-0002-1576-8341)
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1200/op-25-00543
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00